Interline Therapeutics is identifying protein communities to define molecular mechanisms of disease. Dynamics in protein interactions inform cellular and evolutionary biological mechanisms that often become perturbed in disease. The challenge is linking changes in protein interactions with genetic variation caused by mutations. Using their discovery platform, Interline is identifying new medicines targeting genetically validated signaling pathways to ensure that drug candidates comprehensively correct dysfunctional disease networks. This will enable Interline to develop a precision medicine platform to map and modulate protein communities.

Interline Therapeutics

Founded: 2020
Location: South SF, CA
Employee range: 11 - 50
Clinical stage: RD
Therapy area: Undisclosed
Lead product: Undisclosed
Product link: https://www.interlinetx.com/
Funding: $92M May 2021

Short description:

Drug notes:

Long description:

Jobs: